Heusenstamm, Germany

Simon Braun

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Braun. Retrieved from https://idiyas.com/inventor/simon-braun-qmg7pomq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Braun - Innovator in Antibody Purification

Introduction

Simon Braun is a notable inventor based in Heusenstamm, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of antibody purification. His innovative approach has led to the development of a method that enhances the separation of host cell proteins, antibody fragments, and low molecular weight substances from solutions containing antibodies.

Latest Patents

Simon Braun holds 1 patent for his invention titled "Robust antibody purification." This patent outlines a method that improves the efficiency and effectiveness of antibody purification processes, which is crucial for various applications in medical and research settings.

Career Highlights

Simon Braun is currently employed at Merck Patent GmbH, where he continues to work on advancements in biotechnology. His expertise in antibody purification has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Throughout his career, Simon has collaborated with talented individuals such as Mikhail Kozlov and Bianca Edelmann. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

In summary, Simon Braun is a distinguished inventor whose work in antibody purification has made a significant impact in biotechnology. His contributions continue to influence the field and enhance the efficiency of antibody-related processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…